Vaxart, Inc. Presented At The Modern Vaccines Adjuvants & Delivery Systems MVADS 2015

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, a privately held, clinical-stage company developing recombinant vaccines that are administered by tablet rather than by injection, today announced that Vaxart founder and chief scientific officer Sean Tucker, PhD, presented pre-clinical data from its Ebola vaccine program at the Modern Vaccines Adjuvants & Delivery Systems MVADS 2015 in Leiden, NL.

Help employers find you! Check out all the jobs and post your resume.